Search Results - "Osako T"

Molecular detection of lymph node metastasis in breast cancer patients treated with preoperative systemic chemotherapy: a prospective multicentre trial using the one-step nucleic acid amplification assay.

Authors: Osako, T Tsuda, H Horii, R et al.

Source: British Journal of Cancer. 9/17/2013, Vol. 109 Issue 6, p1693-1698. 6p.

Incidence and possible pathogenesis of sentinel node micrometastases in ductal carcinoma in situ of the breast detected using molecular whole lymph node assay.

Authors: Osako, T Iwase, T Kimura, K et al.

Source: British Journal of Cancer. 5/8/2012, Vol. 106 Issue 10, p1675-1681. 7p. 5 Charts.

Accurate staging of axillary lymph nodes from breast cancer patients using a novel molecular method.

Authors: Osako, T Iwase, T Kimura, K et al.

Source: British Journal of Cancer. 10/11/2011, Vol. 105 Issue 8, p1197-1202. 6p. 5 Charts.

Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer: A comparative analysis between one-step nucleic acid amplification whole node assay and routine frozen section histology.

Authors: Osako T Iwase T Kimura K et al.

Source: Cancer (0008543X). Oct2011, Vol. 117 Issue 19, p4365-4374. 10p.

180P Development of prognosis prediction model using cytokeratin 19 mRNA copy number of sentinel lymph node metastasis in breast cancer: A multicenter study in Japan.

Authors: Yotsumoto, D. Osako, T. Matsuura, M. et al.

Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS314-S315. 2p.

Reply: Isolated tumour cells and micrometastases in intraductal breast cancer: a simple mechanical question in some cases.

Authors: Osako, T Iwase, T Akiyama, F

Source: British Journal of Cancer. 5/14/2013, Vol. 108 Issue 9, p1921-1921. 1p.

This result is not displayed to guests.
Login for full access.

624TiP Randomized phase 3 clinical trial evaluating atirmociclib plus letrozole versus a CDK4/6 inhibitor plus letrozole as first-line treatment for patients with HR+/HER2− advanced/metastatic breast cancer.

Authors: Bidard, F.C. Ignatiadis, M. Curigliano, G. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS467-S467. 1p.

108 Poster - Improvement of recurrent rates and survival in patients with primary breast cancer according to subtypes.

Authors: Nakano, M. Nishimura, R. Osako, T. et al.

Source: European Journal of Cancer. 2020 Supplement 1, Vol. 138, pS21-S21. 1p.

Transplant Procurement Management Model Training: Marked Improvement in the Mindset of In-Hospital Procurement Coordinators at Hyogo Prefecture, Japan.

Authors: Yoshikawa, M. Yoshinaga, K. Imamura, Y. et al.

Source: Transplantation Proceedings. Sep2016, Vol. 48 Issue 7, p2437-2441. 5p.

353P - Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer: Results of single arm phase IV COMACHI study.

Authors: Masuda, N. Ohtani, S. Nagai, S. et al.

Source: Annals of Oncology. 2019 Supplement 6, Vol. 30, pv127-v128. 2p.

The Performance of the One Step Nucleic acid Amplification (OSNA) Assay in Breast Cancer Patients with Receiving Preoperative Systemic Therapy.

Authors: Yagata, H. Yamauchi, H. Horii, R. et al.

Source: Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p174-175. 2p.

Changes in re-excision rates after publication of guidelines defining positive margins for breast-conserving surgery: a collaborative study of the Japanese breast cancer society.

Authors: Sakai T Kimura Y Ishitobi M et al.

Corporate Authors: Sakai T Kimura Y Ishitobi M et al.

Source: Breast cancer (Tokyo, Japan) [Breast Cancer] 2026 May; Vol. 33 (3), pp. 761-769. Date of Electronic Publication: 2026 Apr 08.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE

Causes of varied internal echo patterns in ultrasound imaging of breast lymphoma.

Authors: Kokubu Y Osako T Sakai T et al.

Source: Breast cancer (Tokyo, Japan) [Breast Cancer] 2026 May; Vol. 33 (3), pp. 582-592. Date of Electronic Publication: 2026 Apr 07.

Publication Type: Journal Article

Journal Info: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE

Current status and challenges in HER2 IHC assessment: scoring survey results in Japan.

Authors: Sakatani T Tsuda H Yoshida M et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Feb; Vol. 210 (1), pp. 27-36. Date of Electronic Publication: 2024 Nov 04.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Retrospective analysis of survival of patients with HER2-positive breast cancer with microscopic residual invasive disease after neoadjuvant chemotherapy.

Authors: Nishimura M Kobayashi T Aoyama Y et al.

Source: Breast disease [Breast Dis] 2025 Jan-Dec; Vol. 44, pp. 15581551251403784. Date of Electronic Publication: 2025 Dec 05.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 8801277 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-1551 (Electronic) Linking ISSN: 08886008 NLM ISO Abbreviation: Breast Dis Subsets: MEDLINE

Fatal Postoperative Interstitial Lung Disease after Neoadjuvant Nivolumab and Complete Resection for Non-Small Cell Lung Cancer: A Case Report.

Authors: Osako T Shimamura A Takuwa T

Source: Surgical case reports [Surg Case Rep] 2026; Vol. 12 (1). Date of Electronic Publication: 2026 Apr 01.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Springer-Verlag, GmbH Country of Publication: Japan NLM ID: 101662125 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2198-7793 (Print) Linking ISSN: 21987793 NLM ISO Abbreviation: Surg Case Rep Subsets: PubMed not MEDLINE

A 21-Year-Old Female with Invasive Breast Cancer within a Benign Phyllodes Tumor.

Authors: Yoneda H Shimizu Y Bae Y et al.

Source: Surgical case reports [Surg Case Rep] 2026; Vol. 12 (1). Date of Electronic Publication: 2026 Jan 21.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Japan Surgical Society Country of Publication: Japan NLM ID: 101662125 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2198-7793 (Print) Linking ISSN: 21987793 NLM ISO Abbreviation: Surg Case Rep Subsets: PubMed not MEDLINE

Characterizing heterogeneous cis-regulatory elements in gene regulatory programs associated with breast cancer.

Authors: Hori C Kumegawa K Saeki S et al.

Source: Genome medicine [Genome Med] 2025 Nov 27; Vol. 17 (1), pp. 145. Date of Electronic Publication: 2025 Nov 27.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE

Overall survival and subsequent therapy patterns in Japanese patients with ER+/HER2- advanced breast cancer treated with palbociclib plus letrozole in the first-line setting: a final analysis.

Authors: Takahashi M Yasojima H Osako T et al.

Source: Breast cancer (Tokyo, Japan) [Breast Cancer] 2025 Nov; Vol. 32 (6), pp. 1482-1490. Date of Electronic Publication: 2025 Aug 21.

Publication Type: Journal Article; Multicenter Study; Clinical Trial, Phase II

Journal Info: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE